Fovista (pegpleranib) - Iveric bio, Novartis, Roche
Novartis: Q3 2016 Results (Novartis) - Oct 30, 2016 - Anticipated regulatory filing for neovascular AMD in 2017 
Anticipated regulatory • Ophthalmology
https://www.novartis.com/investors/event-calendar#ui-id-1=0&ui-id-5=0&ui-id-2=1
 
Oct 30, 2016
 
 
406b9c75-5443-4205-9730-1347c7d15e5b.jpg